Sharemaestro Newsreel

THOMAS SALICE Exercises Options, Realizes $426K

THOMAS SALICE, a Board Member at Mettler-Toledo Intl (NYSE: MTD), exercised stock options for 417 shares valued at $426,711, as revealed in an SEC filing on August 7. The article also provides a financial overview of Mettler-Toledo Intl, highlighting its revenue growth, debt-to-equity ratio, …

Fulgent Genetics, Inc. (FLGT) Stock Price, News, Quote & History

This article provides a comprehensive overview of Fulgent Genetics, Inc. (FLGT), including its stock price, historical data, company profile, and financial performance. As of August 7, the stock closed at $19.14, up 3.18%. The company specializes in clinical diagnostic and therapeutic development solutions, offering …

Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation

Labcorp (LH) shares have rallied 14% in the past month, driven by strong Q2 earnings, expanding margins, and growth in both Diagnostics Laboratories and Biopharma Laboratory Services. While the company's operating picture has improved significantly, its valuation now sits above its longer-term norm, suggesting …

Revvity, Inc. (0KHE) Q3 2022 Earnings Report - Results, Call & Slides

Revvity, Inc. (0KHE) has released its Q3 2022 earnings report, showing an actual EPS of $1.51, which beat the consensus EPS of $1.44. However, the company missed revenue expectations, reporting $711.80 million against an expected $1.02 billion, a 38.99% year-over-year decrease. The earnings call …

Personalis Inc (PSNL) Stock News Today

Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position

CareDx's recent strong earnings report, while positive on the surface, may not fully reflect the company's underlying financial health. The analysis highlights a high accrual ratio of 0.28, indicating that free cash flow significantly lagged statutory profit, partly due to a US$109m boost from …

People on the Move: Julie Sawyer Montgomery Promoted at Danaher as President and Chief Executive Officer

Danaher Corporation has appointed Julie Sawyer Montgomery as President and Chief Executive Officer, effective October 1, 2026. She succeeds Rainer Blair and brings nine years of experience at Danaher, most recently overseeing the Diagnostics platform. Sawyer Montgomery's appointment reflects her proven track record in …

State Street Corporation (NYSE: STT) discloses 5.3% holding in Myriad Genetics

State Street Corporation has disclosed a 5.3% beneficial ownership in Myriad Genetics, Inc. (MYGN), amounting to 4,985,060 shares. This ownership is managed through various asset management subsidiaries, with shared voting and dispositive power over the shares. The filing, a SCHEDULE 13G, indicates a passive …

The Bull Case For Quest Diagnostics (DGX) Could Change Following Raised Guidance And New Self-Collection Services

A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $45.5 to $46.09

This article provides a quick look at today's analyst ratings for Qiagen NV (QGEN.US), forecasting a target price between $45.50 and $46.09. It highlights the general sentiment and price targets from various financial institutions.

bioAffinity Technologies reports Q2 2026 revenue $1.51M, net loss $3.37M, cash $2.43M

bioAffinity Technologies reported its Q2 2026 financial results, showing revenue of $1.51 million, an increase from $1.27 million in Q2 2025, and a net loss of $3.37 million, an improvement from $4.06 million in Q2 2025. The company's cash and cash equivalents decreased to …

BIAF: Q2 2026 saw 216% CyPath Lung test growth and 19% revenue increase, with improved net loss

BioAffinity Technologies (BIAF) reported significant growth in Q2 2026, with CyPath Lung test volume increasing by 216% and revenue by 19%. This growth was attributed to accelerated physician adoption and expanded clinical trials. Despite increased operating expenses due to commercialization efforts, the company improved …

Revenue Growth Reinforces Twist Bioscience Corp.’s (TWST) Technology Leadership

Myriad Genetics, Inc. (MYGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating Myriad Genetics, Inc. (MYGN) after the company reported Q2 2026 revenues below Wall Street expectations and significantly cut its full-year 2026 revenue guidance. The firm encourages stockholders to contact them to learn more about the investigation into …

Janus Henderson Group PLC Has $5.50 Million Stock Position in CareDx, Inc. $CDNA

Janus Henderson Group PLC has increased its stake in CareDx, Inc. (NASDAQ:CDNA) by 10.1% to 316,519 shares, valued at approximately $5.5 million. This comes as CareDx reported stronger-than-expected quarterly earnings with $0.37 EPS and revenue of $131.95 million, a 52.2% year-over-year increase. Despite a …

Prenetics to Stream Q2 Results on Stocktwits Aug. 18

What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate?

This article analyzes IDEXX Laboratories, Inc.'s stock price movements and valuation, utilizing a discounted cash flow (DCF) model to estimate its intrinsic value. It suggests the stock may be trading below its fair value, indicating potential for growth despite a recent price decline.

CareDx (NASDAQ:CDNA) Is Posting Healthy Earnings, But It Is Not All Good News

Earnings Update: Here's Why Analysts Just Lifted Their Twist Bioscience Corporation (NASDAQ:TWST) Price Target To US$104

Analysts have increased their price target for Twist Bioscience Corporation (NASDAQ:TWST) to US$104 after the company's Q3 results showed revenue exceeding expectations, despite a statutory loss. The upgraded target reflects an improved revenue outlook, with forecasts predicting significant growth in 2027, even though the …

Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC

Empowered Funds LLC significantly reduced its stake in Quest Diagnostics (NYSE:DGX) by 61.5% in the first quarter, selling over 15,000 shares. Despite this, institutional investors still own a substantial 88.06% of the company's stock. Quest Diagnostics exceeded Q1 earnings and revenue expectations, and analysts …

Agilent Technologies Inc. stock outperforms competitors on strong trading day

Agilent Technologies Inc. stock (A) saw a significant rise of 3.28% to $145.97 on Friday, outperforming the broader market indices like the S&P 500 and Dow Jones Industrial Average. This marked the third consecutive day of gains for the stock. The positive performance occurred …

PensionDanmark Pensionsforsikringsaktieselskab Reduces Stock Holdings in Thermo Fisher Scientific Inc. $TMO

PensionDanmark Pensionsforsikringsaktieselskab decreased its stake in Thermo Fisher Scientific Inc. by 5.2% in the second quarter, selling 3,705 shares and retaining 68,031 shares valued at approximately $34.1 million. Despite this reduction, institutional investors collectively own 89.23% of TMO. The company reported strong Q2 earnings …

Is RadNet’s (RDNT) Digital Push Quietly Redefining Its Earnings Power?

Growth Potential For Personalis, Inc. (PSNL): A Look At Its 30% Revenue Surge

Personalis, Inc. (PSNL) shows promising growth in the Diagnostics & Research industry, highlighted by a 30% revenue surge driven by its advanced cancer genomic tests. Despite financial challenges like negative EPS and free cash flow deficits, analyst sentiment remains cautiously optimistic, with potential upside …

Natera Reports Second Quarter 2026 Financial Results

Natera, Inc. announced strong financial results for the second quarter of 2026, with total revenues reaching $752.8 million, a 37.7% increase year-over-year. The company also processed over 1 million tests and saw significant growth in oncology test volumes. Natera raised its 2026 annual revenue …

Loss per share narrows as Natera (Nasdaq: NTRA) grows Q2 revenue

QIAGEN N.V. (NYSE: QGEN) sets $0.35 dividend and $200M buyback cap

QIAGEN N.V. (NYSE: QGEN) announced it will convene its 2026 Annual General Meeting on June 24, 2026. Shareholders will vote on a proposed cash dividend of $0.35 per ordinary share, totaling approximately $72 million, payable July 14, 2026. Additionally, the agenda includes authorizing a …

IQVIA Holdings Inc (IQV) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of IQVIA Holdings Inc (IQV), detailing its current price momentum score, support and resistance levels, and indicator and moving average signals. It notes that the stock is currently suitable for range-bound swing trading, trading between resistance at $256.66 …

CareDx, Inc. (CDNA) Stock Analysis: Strong Revenue Growth and Investor Optimism Signal Potential Upside

Royal Bank of Canada Buys 62,225 Shares of Icon Plc $ICLR

Royal Bank of Canada significantly increased its stake in Icon Plc during the first quarter, purchasing an additional 62,225 shares and bringing its total holdings to 153,728 shares valued at $17 million. This move comes as Icon reported strong quarterly revenues of $2.06 billion, …

GUIDANCE: (SHC) Sotera Health Expects Full Year 2026 Revenue Range $1.24B - $1.25B, Vs. FactSet Est of $1.24B

Sotera Health (SHC) has provided its revenue guidance for the full year 2026, expecting it to fall within the range of $1.24 billion to $1.25 billion. This forecast aligns closely with FactSet's estimated revenue of $1.24 billion for the same period. The guidance offers …

Sotera Health Company Stock 12‑Month Price Target Raised to $21.44, Implies 19% Upside

Sotera Health Company (SHC) has seen its average 12-month price target raised from $20.44 to $21.44 by analysts, implying a 19% potential upside based on its closing price on August 5th. The consensus rating among 10 analysts remains a "Buy," with 8 recommending Buy …

Dimensional Fund Advisors LP Buys 225,588 Shares of NeoGenomics, Inc. $NEO

Dimensional Fund Advisors LP increased its stake in NeoGenomics, Inc. (NASDAQ:NEO) by 9.2% in the first quarter, purchasing an additional 225,588 shares, bringing its total holdings to 2.67 million shares valued at approximately $19.8 million. This acquisition reflects a broader institutional interest in NeoGenomics, …

NeoGenomics, Inc. $NEO Stock Position Raised by Sei Investments Co.

Sei Investments Co. significantly increased its stake in NeoGenomics, Inc. (NASDAQ:NEO) by 320.7% during the first quarter, now holding 466,199 shares valued at $3.46 million. This move is mirrored by other institutional investors, collectively owning 98.5% of the company's stock, despite a recent insider …

Charles River (CRL) Lifts Adjusted EPS Outlook After DSA Beat and Divestiture Hit Has The Bull Case Changed?

Charles River Laboratories International (CRL) reported mixed Q2 2026 results, cutting its GAAP EPS guidance due to divestiture losses but raising its full-year adjusted earnings outlook. This was driven by stronger-than-expected performance in its Discovery and Safety Assessment (DSA) segment, supported by portfolio changes …

Charles River Earnings: Improving Demand Environment Supports Stronger Near-Term Outlook